Apnimed Stock

apnimed.comHealthcare / BioTech & PharmaFounded: 2017Funding to Date: $208.02MM

Apnimed, founded in 2017, is a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders. Apnimed’s lead development program targets the neurologic control of upper airway muscles to maintain an open airway during sleep. Based in Cambridge, MA, the company is developing a portfolio of novel pharmacologic therapies for sleep apnea and related disorders.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Apnimed, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Apnimed’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Apnimed.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Dennis Molnar
Chief Operating Officer
Luigi Montemurro MD
Co-Founder & Chief Scientific Officer
Barry Wohl
Chief Business Officer
Rob Rode
Chief Commercial Officer
Andrew Wellman MD
Co-Founder & Advisor
Ron Farkas Ph.D
Chief Medical Officer
Lawrence Miller MD
Founder & Chief Executive Officer
Michael Rogers
Chief Financial Officer

Board Members

Chris Dimitropoulos
Alpha Wave Global
Isaac Cheng MD
Morningside Group
Stefan Larson Ph.D
Sectoral Asset Management

Apnimed’s stock FAQs


Can you buy Apnimed’s stock?

As Apnimed is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Apnimed, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge's Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Apnimed’s stock?

To invest in a private company like Apnimed’s through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge's marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Apnimed’s stock?

Yes, you may be able to sell your Apnimed’s stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Apnimed’s stock?

If you hold private company shares of Apnimed’s - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Apnimed’s on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Apnimed’s a public company?

No, Apnimed’s is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Apnimed’s stock price?

Apnimed is a privately held company and therefore does not have a public stock price. However, you may access Apnimed’s private market stock price with Forge Data.

What is Apnimed’s stock ticker symbol?

Apnimed does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Apnimed Announces Positive Topline Results for MARIPOSA Trial of AD109, Drug Candidate with the Potential to be the First Oral Therapy for Obstructive Sleep Apnea (OSA)

Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep apnea (OSA) and related disorders, announced today that it has secured $79.75 million in an oversubscribed financing round that extends its Series C financing to a total of $142.25 million.
Updated on: Jul 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.